Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 04, 2024

BUY
$3.46 - $5.33 $446 - $687
129 New
129 $986,000
Q2 2023

Apr 04, 2024

SELL
$6.19 - $8.78 $798 - $1,132
-129 Closed
0 $0
Q4 2022

Apr 04, 2024

BUY
$6.26 - $9.34 $807 - $1,204
129 New
129 $986,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Financial Synergies Wealth Advisors, Inc. Portfolio

Follow Financial Synergies Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.